Last Updated: June 25, 2026

Suppliers and packagers for PHENELZINE SULFATE


✉ Email this page to a colleague

« Back to Dashboard


PHENELZINE SULFATE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Novel Labs Inc PHENELZINE SULFATE phenelzine sulfate TABLET;ORAL 200181 ANDA Lupin Pharmaceuticals,Inc. 43386-360-21 60 TABLET in 1 BOTTLE (43386-360-21) 2010-12-14
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for PHENELZINE SULFATE

Last updated: April 25, 2026

Which suppliers manufacture or supply PHENELZINE SULFATE?

No complete, verifiable supplier dataset is available in the provided material to identify specific manufacturers, API suppliers, or distributors for PHENELZINE SULFATE.

What is “PHENELZINE SULFATE” in supply-chain terms?

PHENELZINE SULFATE is an API/active salt used in pharmaceutical products for which sourcing can occur at three common tiers:

  • API manufacturers (produce phenelzine sulfate drug substance)
  • Intermediates/salt-form converters (salt formation from a phenelzine base)
  • Finished-dose distributors (market the registered drug product, not the API)

A supplier answer requires at minimum: legal entity names, shipment geography (or market coverage), and evidence such as registrations, listings, or confirmed catalog supply. None of that is present in the information provided.

What evidence is required to name suppliers?

To name “suppliers” with business-grade confidence, the supplier list must be backed by one of these record types:

  • Regulatory listings tied to API sourcing (e.g., DMF references, API site listings)
  • Official product catalog listings (API distributors or chemical suppliers)
  • Quality/regulatory attestations (GMP manufacturing statements, COA availability per batch)
  • Corporate supply contracts disclosed in credible documents

No such evidence is available here, so a supplier list cannot be produced.

Supplier coverage map (what can be concluded without names)

Even without specific supplier entities, the supply chain for an older MAOI like phenelzine sulfate typically concentrates in:

  • API manufacturers with controlled substances handling capability (because phenelzine is a regulated psychiatric drug)
  • regional distributors that support antidepressant MAOI distribution channels
  • salt-form capability if phenelzine sulfate is not produced directly from a registered route

This is only structural context and does not identify parties.

Key Takeaways

  • A supplier list for PHENELZINE SULFATE cannot be generated from the information provided.
  • Naming manufacturers or distributors requires verifiable records (regulatory filings, official listings, or documented supply evidence).
  • Supplying “PHENELZINE SULFATE” can refer to API, salt formation, or finished-dose distribution, but the requested supplier scope is not evidenced in the provided material.

FAQs

1) Is PHENELZINE SULFATE the same as PHENELZINE (free base)?

PHENELZINE SULFATE is the sulfate salt form of phenelzine. Salt form affects formulation handling and specifications.

2) Do API suppliers and finished-dose distributors count as “suppliers”?

Yes, but they are different supply tiers. API suppliers manufacture drug substance; distributors may sell finished dosage or source API through intermediates.

3) What documentation is typically used to confirm an API supplier?

GMP manufacturing statements tied to a specific site, COA practices, and regulatory linkages such as DMF-referenced sources or official listings.

4) Why is it harder to compile supplier lists for older MAOIs?

Supply tends to be concentrated, controlled, and managed through established procurement channels, and fewer public catalog listings may exist.

5) What is needed to produce a defensible supplier shortlist?

Named entities plus proof: regulatory references, official catalog listings, or credible procurement disclosures. None are included here.

References

[1]

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.